#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ischaemic stroke Aplastic anaemia Sarcoma Thermal burn Hereditary motor and sensory neuropathy Encephalopathy neonatal Blood iron increased Small intestine adenocarcinoma Hypochromic anaemia Antiphospholipid antibodies Penile cancer Pelizaeus-Merzbacher disease Ocular myasthenia Dent's disease Optic glioma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Treatment KBG syndrome – Treatment Synovial sarcoma metastatic – Diagnostics Glycogen storage disease type II – Diagnostics Choroid melanoma – Basic Information Lennox-Gastaut syndrome – Trials in Disease Congenital generalised lipodystrophy – Basic Information Anaplastic thyroid cancer – Treatment Angiosarcoma metastatic – Diagnostics Alagille syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quinidine Sulfate GXV813 COBALAMIN Linvoseltamab FOSMANOGEPIX PHENTOLAMINE MESILATE R2R01 Vaborbactam Bempedoic Acid SODIUM BENZOATE Melphalan Hydrochloride Marstacimab Corifollitropin Alfa Rosuvastatin Zinc NADOFARAGENE FIRADENOVEC Potassium Exemestane S-241656 Taldefgrobep Alfa L-Lysine Hydrochloride More therapies…

    Learn about Your Condition

    Systemic mastocytosis Renal impairment Ligament operation Seizure Hysterectomy Gastrointestinal disorder Oedema peripheral Herpes zoster Haemoptysis Rectal neoplasm Oxygen therapy Hydrocephalus Hairy cell leukaemia Erythema migrans Cerebral amyloid angiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Comparison of Lidocaine and Ropivacaine in Ultrasound-Guided Nerve Block for Patients with Wrist Fractures Requiring Closed Reduction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Radius fracture
    • Upper limb fracture
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Epinephrine
    • Lidocaine Hydrochloride
    Denmark

  • Study on Metformin for Pain Relief in Patients with Hand Osteoarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Nodal osteoarthritis
    • Osteoarthritis
    Investigated Drugs:
    • Metformin Hydrochloride
    Denmark

  • Study on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Burfiralimab
    Austria Czechia Hungary The Netherlands Poland Spain

  • Safety and effectiveness study of DYNE-101 in patients with Myotonic Dystrophy Type 1 (DM1)

    Not recruiting

    2 1
    Investigated Diseases:
    • Myotonic dystrophy
    Investigated Drugs:
    • Humanised Igg1 Kappa Fragment Antibody Targeting Tfr1 Conjugated To P125 Oligonucleotide
    France Germany Italy The Netherlands

  • Study on Esketamine for Long-term Pain Relief in Patients with Complex Regional Pain Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Complex regional pain syndrome
    Investigated Drugs:
    • Esketamine Hydrochloride
    The Netherlands

  • Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Lonapegsomatropin
    Denmark Ireland
Previous Page
1 … 52 53 54 55 56 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!